BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Brexpiprazole (Rexulti) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Brexpiprazole (Rexulti)\, from ClinicalTr
 ials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07742280-666@assetmemo.bio
DTSTAMP:20261121T005000Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:Brexpiprazole (Rexulti): Phase 2/3 readout est. (NCT07742280)
DESCRIPTION:Brexpiprazole (Rexulti)\, phase 2/3\, Schizophrenia.\nStudy: A 
 Study to Evaluate the Pharmacokinetics\, Safety and Tolerability of Brexpi
 prazole for Extended-Release Injection in Subjects With Schizophrenia\nEst
 imated primary completion: August 2027. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07742280
URL:https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05325645-666@assetmemo.bio
DTSTAMP:20261121T005000Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Brexpiprazole (Rexulti): Phase 3 readout est. (NCT05325645)
DESCRIPTION:Brexpiprazole (Rexulti)\, phase 3\, Schizophrenia.\nStudy: Tria
 l of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Sch
 izophrenia\nEstimated primary completion: September 2027. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT05325645
URL:https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05017311-666@assetmemo.bio
DTSTAMP:20261121T005000Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Brexpiprazole (Rexulti): Phase 4 readout est. (NCT05017311)
DESCRIPTION:Brexpiprazole (Rexulti)\, phase 4\, Major Depressive Disorder.\
 nStudy: Optimized Predictive Treatment In Medications for Unipolar Major D
 epression (OPTIMUM-D)\nEstimated primary completion: 31 December 2028. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/brexpiprazole-rexulti#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT050173
 11
URL:https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07715253-666@assetmemo.bio
DTSTAMP:20261121T005000Z
DTSTART;VALUE=DATE:20300830
DTEND;VALUE=DATE:20300831
SUMMARY:Brexpiprazole (Rexulti): Phase 1 readout est. (NCT07715253)
DESCRIPTION:Brexpiprazole (Rexulti)\, phase 1\, Schizophrenia.\nStudy: Long
 itudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor i
 n Schizophrenia\nEstimated primary completion: 30 August 2030. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07715253
URL:https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04569448-666@assetmemo.bio
DTSTAMP:20261121T005000Z
DTSTART;VALUE=DATE:20300930
DTEND;VALUE=DATE:20301001
SUMMARY:Brexpiprazole (Rexulti): Phase 3 readout est. (NCT04569448)
DESCRIPTION:Brexpiprazole (Rexulti)\, phase 3.\nStudy: Brexpiprazole Treatm
 ent for Bipolar I Depression\nEstimated primary completion: September 2030
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/brexpiprazole-rexul
 ti#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 4569448
URL:https://assetmemo.bio/drug/brexpiprazole-rexulti#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
